Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

NCT04489160 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Traumatic Brain Injury
Trauma, Head

Interventions

DRUG: C1 Inhibitor, Human
DRUG: Placebo

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]